Canada: COVID-19: Vaccine Tracker (February 11, 2021)

On December 9, 2020, just nine months after the World Health Organization declared COVID-19 to be a global pandemic, Health Canada authorized the first COVID-19 vaccine for use in Canada. This milestone, which may soon be followed by other vaccine approvals, is a crucial step towards a distribution campaign that will reach from coast to coast to coast.

Vaccine mobilization will involve a significant number of stakeholders and all levels of government. McCarthy Tétrault is closely monitoring the development of COVID-19 vaccines and their rollout across the country and the world in real time, and we will update this tracker as events unfold. If you require any assistance, please reach out to Awanish Sinha, Matthew Kelleher, or Kate McNeill-Keller.

This roundup was last updated on February 11, 2021.

International

• February 10, 2021: The World Health Organization recommended the Oxford-AstraZeneca COVID-19 vaccine be used widely, including by people over 65. The recommendation comes despite the fact that the vaccine appears to be less effective against some new forms of COVID-19 (link).
• February 9, 2021: South Africa halted its planned rollout of the Oxford-AstraZeneca COVID-19 vaccine after preliminary data suggested that the COVID-19 vaccine offers only minimal protection against the COVID-19 variant that originated in South Africa (link).
• February 4, 2021: Britain launched a trial to assess the immune responses generated if doses from the Pfizer and Oxford-AstraZeneca COVID-19 vaccines are combined in a two-shot schedule. Initial data from this trial is expected in June 2021 (link).
• February 3, 2021: A study on the Oxford-AstraZeneca COVID-19 vaccine found that the vaccine may have a substantial impact in reducing transmission of the virus (link).
• January 29, 2021: The one-dose COVID-19 vaccine produced by Johnson & Johnson was reported to be 66% effective in a large-scale trial across several countries. The vaccine was 85% effective in stopping severe disease and preventing hospitalization (link).
• January 28, 2021: Novavax Inc reported that its COVID-19 vaccine was 89% effective in a trial conducted in the United Kingdom. A mid-stage trial of the vaccine in South Africa, where a new variant of the virus is common, showed 60% effectiveness (link).
• January 26, 2021: Officials in the European Union are threatening to restrict exports and take legal action in response to delivery delays from vaccine makers AstraZeneca and Pfizer (link).
• January 25, 2021: Moderna said its COVID-19 vaccine produced virus-neutralizing antibodies in tests against new coronavirus variants found in the UK and South Africa (link).
• January 22, 2021: Morocco received 2 million doses of the Oxford-AstraZeneca COVID-19 vaccine, becoming the first country in Africa to receive a vaccine shipment large enough to begin a nationwide immunization program (link).
• January 20, 2021: India began exporting Oxford-AstraZeneca's COVID-19 vaccine to neighbouring and key partner countries. The shipments will be among the first in the world directed to mid-income and lower-income countries (link).
• January 19, 2021: Russia's consumer health watchdog reported that a candidate COVID-19 vaccine known as "EpiVacCorona" proved 100% effective in early-stage trials (link).
• January 13, 2021: The COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac was found to be 50.4% effective, much lower than the 78% effectiveness previously announced (link).
• January 11, 2021: Pfizer plans to produce 2 billion doses of the Pfizer COVID-19 vaccine this year, a 50% increase from the previous expected output (link).
• January 8, 2021: The United Kingdom approved the Moderna COVID-19 vaccine (link).
• January 8, 2021: World Health Organization experts issued recommendations that the first and second doses of the Pfizer COVID-19 vaccine can be administered up to six weeks apart (link).
• January 8, 2021: A Pfizer study suggests that the Pfizer COVID-19 vaccine works against the new COVID-19 variants found in the United Kingdom and in South Africa (link).
• January 6, 2021: The European Union authorized the use of the Moderna COVID-19 vaccine, the second vaccine to be approved. Member states of the European Union lag considerably behind other countries in vaccination efforts (link).
• January 5, 2021: Moderna and Pfizer scientists say there is no evidence that COVID-19 vaccines currently being deployed will not protect against the new COVID-19 variant (link).
• January 4, 2021: The United Kingdom began administering the Oxford-AstraZeneca COVID-19 vaccine (link).
• December 31, 2020: Chinese health regulators gave conditional approval for the Sinopharm COVID-19 vaccine (link).
• December 30, 2020: The United Kingdom approved the Oxford-AstraZeneca COVID-19 vaccine. The vaccine requires two doses and can be stored and transported under normal refrigeration (link).
• December 29, 2020: An affiliate of China's state-owned drug maker Sinopharm requested regulatory approval in China for a COVID-19 vaccine. The vaccine showed 79% efficacy and would be China's first approved vaccine for general public use (link).
• December 28, 2020: Novavax has begun a large late-stage study of its experimental COVID-19 vaccine in the United States (link).
• December 27, 2020: The AstraZeneca COVID-19 vaccine is expected to be approved by U.K. authorities within the week and is believed to be effective against a new variant of COVID-19 that was first found in Britain (link).
• December 22, 2020: Pfizer and Moderna both announced that they are testing their vaccines against the mutated version of the virus found in the United Kingdom. Moderna expects its vaccine to be protective against the new variant (link).
• December 21, 2020: The European Medicines Agency has authorized Pfizer's COVID-19 vaccine for use in the European Union. Distribution in some EU states could begin as early as Sunday (link).
• December 20, 2020: The U.S. Advisory Committee on Immunization Practices voted to recommend to the U.S. Centre for Disease Control that adults aged 75 and older and frontline essential workers be prioritized for COVID-19 vaccines (link).
• December 20, 2020: Distribution of the Moderna COVID-19 vaccine to vaccination sites began in the U.S. (link).
• December 18, 2020: COVAX, a World Health Organization-affiliated organization aimed at ensuring rapid and income-equitable access to COVID-19 vaccines for all countries, announced that it has made arrangements to provide at least 1.3 billion donor-funded doses to 92 economically eligible countries by the end of 2021 (link).
• December 17, 2020: The Chief of the European Commission announced that vaccinations will start across European Union states on December 27, 28, and 29 (link).
• December 15, 2020: The Moderna COVID-19 vaccine is set for regulatory approval in the U.S., as the U.S. Food and Drug Administration did not raise any major concerns about the vaccine in newly released documents (link).
• December 13, 2020: Pfizer began distributing doses to vaccination sites in the United States (link).
• December 11, 2020: Sanofi and GlaxoSmithKline said that their potential COVID-19 vaccine would undergo further study in February 2021 after trials showed an insufficient immune response in adults over 50. This will delay the vaccine's potential launch until the end of 2021 (link).
• December 10, 2020: The National Health Service (NHS) of the United Kingdom advised that people with a history of significant allergic reactions should not receive the Pfizer vaccine after two NHS workers had allergic reactions on Tuesday, December 8, 2020. Several thousand vaccines have been administered since the rollout began. Both individuals are recovering (link).
• December 8, 2020: The United Kingdom began the rollout of the Pfizer vaccine to the public, launching the global COVID-19 immunization effort (link).

• February 9, 2021: A senior medical adviser with Health Canada confirmed that the agency is in its final stages of reviewing the Oxford-AstraZeneca COVID-19 vaccine (link).
• February 9, 2021: Health Canada agreed with a request from Pfizer to recognize that each vial of the company's COVID-19 vaccine includes six doses, not five (link).
• February 3, 2021: Procurement Minister Anand stated that 1.1 million doses of the Oxford AstraZeneca COVID-19 vaccine could arrive by the end of March through a World Health Organization program that Canada contributed to in September, 2020. Health Canada has not yet approved the Oxford AstraZeneca COVID-19 vaccine (link).
• February 2, 2021: The European Commission stated it will only apply COVID-19 vaccine export control restrictions to Canada and other countries in very limited cases (link).
• February 2, 2021: The federal government entered into a deal with Novavax to produce its COVID-19 vaccine in Canada (link).
• January 28, 2021: The federal government informed the provinces that Canada would be receiving only 3.5 million doses of the Pfizer COVID-19 vaccine by the end of March, down from the initial commitment of 4 million doses. The reduction is based in Pfizer's assertion that six doses of its vaccine can be extracted from each vial instead of five, which Canadian regulators have not approved (link).
• January 27, 2021: Indigenous Services Canada announced that vaccinations have begun in 196 communities for First Nations or Inuit across the country (link).
• January 26, 2021: Prime Minister Trudeau stated that he remains confident in Canada's COVID-19 vaccine supplies despite the potential for European nations to impose export controls (link).
• January 26, 2021: Providence Therapeutics said it will begin human clinical trials in Toronto of its own COVID-19 vaccine (link).
• January 21, 2021: The Prime Minister said that he spoke with the CEO of Pfizer to discuss timely COVID-19 vaccine deliveries to Canada, and stated that he received assurances that 4 million doses of the Pfizer COVID-19 vaccine will be received by the end of March (link).
• January 20, 2021: Indigenous Services Canada announced that vaccinations have begun in 169 communities for First Nations or Inuit in all provinces and territories except Nova Scotia and Prince Edward Island (link).
• January 19, 2021: Canada will receive 82% of the COVID-19 vaccine doses it initially expected from Pfizer during the week of January 18, 2021 and will receive no deliveries of the Pfizer COVID-19 vaccine during the week of January 25, 2021 (link).
• January 15, 2021: Pfizer will temporarily reduce shipments of its COVID-19 vaccine to Canada as it is pausing some of its production lines in order to expand long-term manufacturing capacity. The company believes it will be able to catch up on the missed shipments by the end of March (link).
• January 14, 2021: Canada is expected to receive up to one million doses a week of COVID-19 vaccines starting in April (link).
• January 13, 2021: The National Advisory Committee on Immunizations stated that every effort should be made to follow the 21-day and 28-day dosing schedules recommended for the COVID-19 vaccines approved in Canada, but that the second dose can be delayed briefly in order to distribute vaccines in an efficient manner (link).
• January 12, 2021: Canada secured another 20 million doses of the Pfizer COVID-19 vaccine (link).
• January 12, 2021: Several teams of Canadian researchers across the country are building infrastructure for facilities to make COVID-19 vaccines with the help of new federal funding (link).
• January 11, 2021:Canada opted not to exercise an option to buy up to 16 million additional doses of the Moderna COVID-19 vaccine as the doses would not arrive until late 2021 (link).
• January 10, 2021: The Procurement Minister's office said the federal government chose not to exercise its option to buy up to 16 million more doses of the Moderna COVID-19 vaccine. The federal government had an option to receive up to 56 million doses total, and has already ordered 40 million doses (link).
• January 10, 2021: The Public Health Agency of Canada issued a statement on mRNA vaccines and how they operate (link).
• January 6, 2021: Correctional Services Canada announced the start of vaccinations of older vulnerable federal inmates as part of the vaccine rollout recommended by the National Advisory Committee on Immunization. The Moderna COVID-19 vaccine will be used for these vaccinations (link).
• January 5, 2021: Prime Minister Trudeau said he is frustrated by the provinces' slow pace of COVID-19 vaccine rollout. Canada has received more than 424,050 doses of COVID-19 vaccine, but only 35% of these doses have been administered. Alberta, British Columbia, and PEI have administered the most doses on a per capita basis, while Manitoba has administered the fewest. Canada has been outpaced in its vaccination effort by the United States, the United Kingdom, Bahrain, Israel, Denmark, and the United Arab Emirates among others (link).
• December 30, 2020: Health Canada issued a statement acknowledging that the United Kingdom authorized the use of the Oxford-AstraZeneca COVID-19 vaccine, but that Canada's review process is ongoing. Health Canada requires further information and data from AstraZeneca before it can authorize the vaccine (link).
• December 27, 2020: The first batch of doses of the Moderna COVID-19 vaccine arrived in Canada from Brussels via FedEx Express, with FedEx Canada responsible for physical deliveries in the country (link).
• December 23, 2020: Health Canada authorized the Moderna COVID-19 vaccine for use in Canada. It is the second COVID-19 vaccine to be approved (link). Canada is expected to receive up to 168,000 doses of the vaccine in December, 2020 and 40 million doses by the end of 2021(link).
• December 21, 2020: Moderna has provided the final documents necessary for Health Canada to determine whether it can authorize the company's COVID-19 vaccine (link).
• December 18, 2020: Health Canada issued a statement acknowledging that the U.S. Food and Drug Administration has authorized the use of the Moderna COVID-19 vaccine, but that Canada's review process is ongoing. The department stated that while it cannot provide a definite timeline, it expects its review will be completed in the coming weeks (link).
• December 16, 2020: The Public Health Agency of Canada said in a statement to CBC News that Canada expects to have enough vaccine doses available to vaccinate every Canadian who would like to be inoculated by the end of September 2021. This date is based on the companies that Canada has signed purchase agreements with securing regulatory approvals and meeting delivery timelines (link).
• December 15, 2020: Canada will have access to 168,000 doses of the Moderna COVID-19 vaccine in December 2020, pending approval of the vaccine by Health Canada. Delivery of the Moderna vaccine is expected to begin within 48 hours of approval. Prime Minister Trudeau announced that the first doses of the Moderna vaccine will be directed to northern regions, remote and indigenous communities, as it has less stringent storage requirements than the Pfizer vaccine (link).
• December 15, 2020: Canada will receive up to 200,000 additional doses of the Pfizer COVID-19 vaccine next week (link).
• December 11, 2020: The Prime Minister stated that Canada's first doses of the vaccine have arrived in the country (link).
• December 10, 2020: The Prime Minister announced that the Federal Government would cover costs associated with COVID-19 vaccines, including the costs to administer them (link).
• December 10, 2020: The Public Health Agency of Canada announced that it is implementing a no-fault vaccine injury support program for all Health Canada approved vaccines. This program, in collaboration with all provinces and territories, will provide Canadians with support in the event of an adverse reaction to a vaccine (link).
• December 9, 2020: Health Canada announced its approval of the Pfizer vaccine, becoming the first COVID-19 vaccine authorized in Canada (link).

• December 7, 2020: The Minister of Public Services and Procurement announced that Canada will receive up to 249,000 Pfizer vaccine doses in December 2020, contingent upon Health Canada's approval of the vaccine (link).

• December 4, 2020: The Government of Canada released a guide outlining the federal government's immunization plan. The plan is comprised of seven key elements and the roles of key stakeholders in the plan (link).

• February 10, 2021: Since the start of immunizations, 157,797 doses of a COVID-19 vaccine have been administered in British Columbia. 14,316 people have received both doses (link).
• February 8, 2021: The Provincial Health Officer said that the province is on track to begin mass immunization clinics in March of 2021, with people over the age of 80 to be the first to receive a COVID-19 vaccine (link).
• February 5, 2021: Since the start of immunizations, 149,564 doses of a COVID-19 vaccine have been administered in British Columbia. 10,366 people have received both doses (link).
• February 3, 2021: Since the start of immunizations, 142,146 doses of a COVID-19 vaccine have been administered in British Columbia. 6,417 people have received both doses (link).
• January 29, 2021: Since the start of immunizations, 129,241 doses of a COVID-19 vaccine have been administered in British Columbia. 4,262 people have received both doses (link).
• January 27, 2021: Since the start of immunizations, 124,365 doses of a COVID-19 vaccine have been administered in British Columbia. 4,160 people have received both doses (link).
• January 26, 2021: The Provincial Health Officer confirmed 56 reports of adverse reactions from COVID-19 vaccines (link).
• January 22, 2021: The Government of British Columbia is expected to imminently release details regarding the province's next steps in its COVID-19 vaccination plan (link).
• January 20, 2021: Since the start of immunizations, 98,125 people have received a COVID-19 vaccine in British Columbia (link).
• January 19, 2021: Health officials in British Columbia are expecting a temporary shortfall of roughly 60,000 doses of the Pfizer COVID-19 vaccine in the coming weeks as a result of Pfizer's previously announced delays (link).
• January 15, 2021: Since the start of immunizations, 75,914 people have received a COVID-19 vaccine in British Columbia (link).
• January 15, 2021: Close to 60 First Nations in British Columbia are expected to receive COVID-19 vaccine doses next week. The shipments are being prioritized based on remoteness and whether a community has experienced a cluster of COVID-19 cases or deaths from the virus (link).
• January 13, 2021: Since the start of immunizations, 63,430 people have received a COVID-19 vaccine in British Columbia (link).
• January 11, 2021: The Provincial Health Officer said that British Columbia will allow a 35-day gap between doses of the COVID-19 vaccine to maximize distribution while balancing supply (link).
• January 11, 2021: British Columbia is set to receive 80,000 doses of the Pfizer and Moderna COVID-19 vaccines combined per week by the end of February, 2021 (link).
• January 8, 2021: Since the start of immunizations, 46,259 people have received a COVID-19 vaccine in British Columbia (link).
• January 6, 2021: Since the start of immunizations, 33,665 people have received a COVID-19 vaccine in British Columbia (link).
• January 5, 2021: British Columbia aims to provide vaccines to 3,300 people a day for the next two weeks, with the second dose being administered 35 days after the first (link).
• January 3, 2021: Since the start of immunizations, 17,510 people have received a COVID-19 vaccine in British Columbia (link).
• December 29, 2020: Since the start of immunizations, 11,930 people have received a COVID-19 vaccine in British Columbia (link).
• December 27, 2020: The Provincial Health Officer said that British Columbia's first batch of the Moderna COVID-19 vaccine could arrive as early as Tuesday, December 29 (link).
• December 22, 2020: Vaccine clinics opened in the Island Health, Interior Health, and Northern Health regions. Since the start of immunizations, 4,108 people have received the Pfizer COVID-19 vaccine in British Columbia (link).
• December 21, 2020: The Minister of Health and Provincial Health Officer confirmed that 3,644 front-line health workers received the Pfizer COVID-19 vaccine last week (link).
• December 16, 2020: The Minister of Health and Provincial Health Officer said in a joint statement that every health region in the province will receive weekly vaccine deliveries starting the week of December 21 (link).
• December 15, 2020: The first British Columbians were vaccinated against COVID-19, with approximately 4,000 health-care workers to receive the vaccine in the coming days from its first batch (link).
• December 14, 2020: British Columbia received its first batch of approximately 4,000 doses of the Pfizer COVID-19 vaccine (link).
• December 10, 2020: The Provincial Health Officer stated that the Ministry of Health is working with the RCMP to protect vaccine transportation after receiving information about efforts to sabotage immunization programs (link).
• December 9, 2020: The Provincial Health Officer announced that the province plans on immunizing 400,000 people by the end of March, with priority given to residents and staff of long-term care homes and and health-care workers. By April 2021, prioritization will include teachers, grocery store workers, firefighters, and people working in food processing facilities (link).
• December 9, 2020: The Government of British Columbia announced that a COVID-19 vaccine registration and record system is in development. The system will include a process to register for vaccine access and receive a formal immunization record (link).

• December 9, 2020: The Government of British Columbia announced that the first round of 4,000 vaccinations will begin during the week of December 14, 2020 at two sites in the Lower Mainland, expanding to nine sites by January 2021. The initial vaccinations will be administered to Lower Mainland health-care workers in long-term care homes and front-line health-care workers essential to the COVID-19 response (link).

• February 10, 2021: Since the start of immunizations, 129,452 doses of a COVID-19 vaccine have been administered in Alberta. 36,999 people have received both doses (link).
• February 9, 2021: The Kehewin Cree Nation received its first 100 doses of the Moderna COVID-19 vaccine on February 8, 2021 (link).
• February 3, 2021: Since the start of immunizations, 109,341 doses of a COVID-19 vaccine have been administered in Alberta. 18,970 people have received both doses (link).
• January 27, 2021: Since the start of immunizations, 101,123 doses of a COVID-19 vaccine have been administered in Alberta. 11,362 people have received both doses (link).
• January 20, 2021: Since the start of immunizations, 95,243 doses of a COVID-19 vaccine have been administered in Alberta (link).
• January 19, 2021: Premier Jason Kenney said that the province has run out of COVID-19 vaccines. The province paused first dose appointments and postponed the roll-out to First Nations communities and general population seniors (link).
• January 15, 2021: Minister of Health, Tyler Shandro, issued a statement indicating the government is unsure of how the reduction of the Pfizer COVID-19 vaccine supply will affect the planned roll-out of immunizations in the province (link).
• January 13, 2021: Since the start of immunizations, 58,144 doses of a COVID-19 vaccine have been administered in Alberta. The Province has also expanded COVID-19 vaccination eligibility to include paramedics and emergency medical technicians (link).
• January 12, 2021: Premier Kenney stated that Alberta should be able to open up the vaccination program to the general public by around June 2021 (link).
• January 11, 2021: The Premier of Alberta said the province is running out of COVID-19 vaccines and could exhaust its supply as early as next week (link).
• January 8, 2021: Alberta added health care workers in medical, surgical, and COVID-19 vaccine units to the list of those eligible to receive a COVID-19 vaccine (link).
• January 7, 2021: Since the start of immunizations, 37,686 doses of a COVID-19 vaccine have been administered in Alberta (link).
• January 6, 2021: Since the start of immunizations, 30,033 doses of the COVID-19 vaccine have been administered in Alberta (link).
• January 6, 2021: Alberta expects to receive an additional 13,000 doses of the Pfizer COVID-19 vaccine in the coming days (link).
• January 4, 2021: Alberta has received roughly 46,000 doses of the Moderna and Pfizer COVID-19 vaccines, combined (link).
• December 29, 2020: The first shipment of the Moderna COVID-19 vaccine arrived in Alberta. The 16,900 doses will be directed to residents and staff in long-term care centres (link).
• December 28, 2020: A total of 6,016 doses of COVID-19 vaccine have been administered in Alberta (link).
• December 22, 2021: Alberta has received a second shipment of the Pfizer COVID-19 vaccine, containing 25,350 vaccine doses (link).
• December 21, 2021: Alberta will receive 25,350 doses of the Pfizer COVID-19 vaccine during the week of December 21, 2020 (link).
• December 15, 2020: The first Albertans were vaccinated against COVID-19 with the Pfizer COVID-19 vaccine. Vaccines are being offered in Calgary and Edmonton to respiratory therapists, intensive care unit physicians and staff, and eligible long-term care and designated supportive living workers (link).
• December 14, 2020: Alberta received 3,900 doses of the Pfizer COVID-19 vaccine, with a further 25,350 vaccines expected to arrive in Alberta on December 21 (link).
• December 9, 2020: The Government of Alberta announced that its first shipment of the Pfizer vaccine will arrive during the week of December 14, 2020. The initial vaccinations will focus on health-care workers at high-risk facilities, expanding to other health-care workers in January 2021. Eight locations across the province are equipped to store the vaccine. Phase 1 of the province's rollout, focused on other priority groups, will begin in January 2021(link).

• December 7, 2020: Government officials told the CBC that the first shipment of the Pfizer vaccine to the province will contain 3,900 doses (link).

• November 28, 2020: The Premier stated that COVID-19 vaccination will not be mandatory (link).

• February 10, 2021: Since the start of immunizations, 45,371 doses of a COVID-19 vaccine have been administered in Saskatchewan. Saskatchewan is expected to receive 1,950 doses of the Pfizer COVID-19 vaccine on February 11, 2021 (link).
• February 9, 2021: The Government of Saskatchewan released its COVID-19 Immunization Delivery Plan. Phase two of vaccination sequencing in the province will focus on the general population in 10-year increments, starting with ages 60-69 (link).
• February 6, 2021: Since the start of immunizations, 41,254 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• February 4, 2021: Saskatchewan is expected to receive 6,000 doses of the Moderna COVID-19 vaccine on February 5, 2021 for distribution in the Far North, North, and Central West zones of the province (link).
• February 3, 2021: Since the start of immunizations, 35,763 doses of a COVID-19 vaccine have been administered in Saskatchewan. 5,039 people have received both doses (link).
• February 1, 2021: Saskatoon's VIDO-InterVac began clinical trials of its COVID-19 vaccine (link).
• January 31, 2021: Since the start of immunizations, 35,359 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• January 27, 2021: Since the start of immunizations, 34,615 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• January 26, 2021: The Premier stated that Saskatchewan has virtually run out of COVID-19 vaccines but is expected to receive more than 12,000 doses during the week of February 1, 2021. (link).
• January 24, 2021: Since the start of immunizations, 33,039 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• January 21, 2021: The Government of Saskatchewan received 2,925 doses of the Pfizer COVID-19 vaccine during the week of January 18, 2021. These COVID-19 vaccine doses will be distributed to priority populations in four areas (link).
• January 21, 2021: The Government of Saskatchewan announced that the administration of a first COVID-19 vaccine dose has been completed for long-term care homes in more than 40 communities. The Government also announced that it would implement recommendations to extend the time between the first and second COVID-19 vaccine doses up to 42 days where operationally necessary in order to deliver more first doses to eligible people (link).
• January 20, 2021: Since the start of immunizations, 27,233 doses of a COVID-19 vaccine have been administered in Saskatchewan. A shipment of the Pfizer COVID-19 vaccine received during the week of January 18, 2021 will allow limited vaccinations to continue into the week of January 25, 2021 (link).
• January 19, 2021: The Government of Saskatchewan is expecting to run out of COVID-19 vaccine in the next few days. The shortage should not have an impact on those requiring a second dose (link).
• January 18, 2021: Seniors over the age of 70 and living in the city of Prince Albert are now eligible to receive a COVID-19 vaccine (link).
• January 17, 2021: Since the start of immunizations, 20,159 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• January 14, 2021: Saskatchewan updated its COVID-19 vaccine distribution plan based on the expected allocations of vaccines from the federal government ( link).
• January 13, 2021: Since the start of immunizations, 10,400 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• January 12, 2021: Premier Moe acknowledged Saskatchewan's slow start to the vaccine rollout and stated that changes were being made to increase the speed of distribution (link).
• January 10, 2021: Since the start of immunizations, 7,929 doses of a COVID-19 vaccine have been administered in Saskatchewan (link).
• January 7, 2021: Saskatchewan announced that the province will receive more than 11,000 doses of the Pfizer COVID-19 vaccine weekly beginning in February, 2021 (link).
• January 6, 2021: Since the start of immunizations, 4,524 doses of the COVID-19 vaccine have been administered in Saskatchewan. All remaining Moderna COVID-19 vaccine doses received to date have been allocated to the province's far North East and North East zones (link).
• January 5, 2021: Immunization against COVID-19 began in Saskatchewan's Far North, using the Moderna COVID-19 vaccine (link).
• January 4, 2021: The Health Minister announced the province expects to receive 6,825 doses of the Pfizer COVID-19 vaccine for each of the weeks of January 11, 18, and 25, a downward revision from 10,725 doses each week (link).
• January 3, 2021: Since the start of immunizations, 3,866 doses of the COVID-19 vaccine have been administered in Saskatchewan (link).
• December 28, 2020: Since the start of immunizations, 2,371 doses of the COVID-19 vaccine have been administered in Saskatchewan (link).
• December 23, 2020: The government of Saskatchewan announced that 4,900 doses of the Moderna COVID-19 vaccine would be arriving in Saskatchewan the week of December 28, 2020 (link).
• December 22, 2020: Immunization against COVID-19 began in Saskatoon, with 1,950 health-care workers expected to receive their first dose of the Pfizer COVID-19 vaccine in the coming days (link).
• December 21, 2020: The total COVID-19 vaccinations completed to December 21 is 1,519 (link).
• December 20, 2020: The total COVID-19 vaccinations completed to December 20 is 1,285 (link).
• December 17, 2020: Saskatchewan received a second shipment of the Pfizer vaccine, expanding its pilot vaccination project to frontline staff in the Saskatchewan Cancer Agency, Emergency Medical Services (EMS), and anesthetists (link).
• December 15, 2020: Saskatchewan received its first shipment of the Pfizer COVID-19 vaccine and began administering the 1,950 doses at Regina General Hospital to health-care workers (link).
• December 11, 2020: The Office of the Information and Privacy Commissioner of Saskatchewan released an advisory addressing questions around the approval, delivery, and administration of vaccines (link).
• December 9, 2020: The Government of Saskatchewan released its COVID-19 Vaccine Delivery Plan, with the first shipment containing 1,950 Pfizer vaccine doses expected to arrive by December 15, 2020. The initial vaccines will be delivered to health-care workers providing direct care to COVID-19 patients. The first phase of the Delivery Plan following the initial shipment will focus on higher-risk populations and will begin in December 2020. 202,052 vaccine doses are expected within the first quarter of 2021 (link).

• December 1, 2020: The Health Minister said that COVID-19 vaccination will not be mandatory (link).

To view the original article click here

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.